Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

336 trials

Showing 20 of 336 results

Not applicableTemporarily pausedNCT04419779
What this trial is testing

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Fractyl Health Inc. 320
Large-scale testing (Phase 3)Study completedNCT00313313
What this trial is testing

Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

Who this might be right for
Diabetes
AstraZeneca 768
Large-scale testing (Phase 3)Study completedNCT00094770
What this trial is testing

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 1,172
Large-scale testing (Phase 3)Study completedNCT00541775
What this trial is testing

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 273
Post-approval studies (Phase 4)Study completedNCT03770052
What this trial is testing

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

Who this might be right for
Type 2 Diabetes MellitusInadequate Glucose Control
Pusan National University Hospital 159
Large-scale testing (Phase 3)Study completedNCT05504226
What this trial is testing

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

Who this might be right for
Type 2 Diabetes
Handok Inc. 214
Large-scale testing (Phase 3)Study completedNCT03242252
What this trial is testing

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 3
Lexicon Pharmaceuticals 787
Large-scale testing (Phase 3)Study completedNCT01422876
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,405
Large-scale testing (Phase 3)UnknownNCT03851432
What this trial is testing

Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sihuan Pharmaceutical Holdings Group Ltd. 390
Early research (Phase 1)Study completedNCT00511108
What this trial is testing

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC 211
Large-scale testing (Phase 3)Study completedNCT00683878
What this trial is testing

Add-on to Thiazolidinedione (TZD) Failures

Who this might be right for
Type 2 Diabetes
AstraZeneca 972
Large-scale testing (Phase 3)Study completedNCT00996658
What this trial is testing

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 278
Large-scale testing (Phase 3)Study completedNCT02794792
What this trial is testing

Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Europe B.V. 268
Large-scale testing (Phase 3)Study completedNCT00095030
What this trial is testing

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
Bristol-Myers Squibb 1,752
Large-scale testing (Phase 3)Looking for participantsNCT06589765
What this trial is testing

HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 800
Large-scale testing (Phase 3)Study completedNCT02121717
What this trial is testing

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 535
Testing effectiveness (Phase 2)Looking for participantsNCT06647550
What this trial is testing

To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Hyundai Pharm 160
Large-scale testing (Phase 3)Study completedNCT00601250
What this trial is testing

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 701
Large-scale testing (Phase 3)Study completedNCT00960076
What this trial is testing

An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 282
Large-scale testing (Phase 3)Ended earlyNCT03608358
What this trial is testing

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 41
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation